Exelon Co. (EXC) Shares Sold by CENTRAL TRUST Co

CENTRAL TRUST Co reduced its position in shares of Exelon Co. (NYSE:EXC) by 12.0% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,574 shares of the energy giant’s stock after selling 2,260 shares during the period. CENTRAL TRUST Co’s holdings in Exelon were worth $831,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently made changes to their positions in EXC. First Bank & Trust acquired a new position in shares of Exelon during the first quarter worth $25,000. Csenge Advisory Group acquired a new position in shares of Exelon during the third quarter worth $26,000. Moody National Bank Trust Division acquired a new position in shares of Exelon during the fourth quarter worth $26,000. Braun Bostich & Associates Inc. increased its holdings in shares of Exelon by 51.7% during the fourth quarter. Braun Bostich & Associates Inc. now owns 613 shares of the energy giant’s stock worth $28,000 after buying an additional 209 shares in the last quarter. Finally, Capital Financial Planning LLC acquired a new position in shares of Exelon during the fourth quarter worth $29,000. Institutional investors and hedge funds own 80.15% of the company’s stock.

Shares of Exelon stock opened at $50.47 on Monday. The company has a current ratio of 1.17, a quick ratio of 1.02 and a debt-to-equity ratio of 1.04. Exelon Co. has a twelve month low of $39.10 and a twelve month high of $51.03. The firm has a market capitalization of $48.95 billion, a P/E ratio of 16.18, a price-to-earnings-growth ratio of 3.22 and a beta of 0.37.

Exelon (NYSE:EXC) last issued its quarterly earnings data on Friday, February 8th. The energy giant reported $0.58 earnings per share for the quarter, topping the consensus estimate of $0.57 by $0.01. Exelon had a net margin of 5.58% and a return on equity of 9.18%. The company had revenue of $8.81 billion for the quarter, compared to analysts’ expectations of $6.60 billion. During the same quarter in the previous year, the firm posted $0.55 earnings per share. Exelon’s revenue for the quarter was up 5.1% on a year-over-year basis. As a group, sell-side analysts predict that Exelon Co. will post 3.13 earnings per share for the current fiscal year.

Several research analysts have recently issued reports on the stock. Goldman Sachs Group upgraded shares of Exelon from a “sell” rating to a “neutral” rating and upped their price target for the stock from $43.00 to $47.00 in a report on Tuesday, April 9th. Wells Fargo & Co upgraded shares of Exelon from a “market perform” rating to an “outperform” rating and upped their price target for the stock from $50.00 to $57.00 in a report on Tuesday, April 2nd. Scotiabank reiterated a “buy” rating and set a $50.00 price target on shares of Exelon in a report on Wednesday, February 13th. SunTrust Banks reiterated a “hold” rating and set a $49.00 price target on shares of Exelon in a report on Tuesday, February 12th. Finally, Morgan Stanley upped their price target on shares of Exelon from $47.00 to $49.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 12th. Seven research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $47.82.

In other Exelon news, EVP Paymon Aliabadi sold 17,500 shares of the company’s stock in a transaction on Monday, March 4th. The shares were sold at an average price of $48.36, for a total transaction of $846,300.00. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, EVP Joseph Nigro sold 53,800 shares of the company’s stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $49.59, for a total transaction of $2,667,942.00. Following the sale, the executive vice president now directly owns 99,574 shares in the company, valued at approximately $4,937,874.66. The disclosure for this sale can be found here. In the last three months, insiders sold 88,800 shares of company stock worth $4,352,142. 0.27% of the stock is currently owned by insiders.

WARNING: “Exelon Co. (EXC) Shares Sold by CENTRAL TRUST Co” was posted by Transcript Daily and is owned by of Transcript Daily. If you are reading this piece on another site, it was illegally stolen and republished in violation of international trademark & copyright legislation. The original version of this piece can be viewed at https://transcriptdaily.com/2019/04/29/exelon-co-exc-shares-sold-by-central-trust-co.html.

About Exelon

Exelon Corporation, a utility services holding company, engages in energy generation and delivery businesses in the United States and Canada. It owns nuclear, fossil, wind, hydroelectric, and solar generating facilities. The company also sells electricity to wholesale and retail customers; and sells natural gas, renewable energy, and other energy-related products and services.

See Also: Dividend

Want to see what other hedge funds are holding EXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exelon Co. (NYSE:EXC).

Institutional Ownership by Quarter for Exelon (NYSE:EXC)

Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.